PD-032 Is there an impact of the number of metastases in the outcome of potentially resectable metastatic colorectal cancer patients receiving bevacizumab-based regimen in 1st line...

Por Metges, J.-P., Bennouna, J., Rivoire, M., Elias, D., Bonnetain, F., Dourthe, L., Ben Abdelghani, M., Radji, R., Laplaige, P., Petit Laurent, F., Sébastien, K., Telliez, J., Malka, D.
Publicado no Ann Oncol (2016)